LABD
Direxion Daily S&P Biotech Bear 3X ETF
stockNYSEETF
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 7.18 | 2026-09-28 | +4.32% | 2.095 |
| 1M | 6.45 | 2026-09-04 | +16.12% | -3.132 |
| 3M | 7.34 | 2026-07-06 | +2.04% | -2.606 |
| 6M | 15.88 | 2026-04-06 | -52.83% | -2.710 |
| 1Y | 36.54 | 2025-10-06 | -79.50% | -3.082 |
| 2Y | 60.80 | 2024-10-04 | -87.68% | — |
| 5Y | 224.00 | 2021-10-05 | -96.66% | -3.376 |
Direxion Daily S&P Biotech Bear 3X ETF (NYSE:LABD) stock price today is $7.49, and today's volume is 21,744,287. LABD is up 0.402% today. The 30 day average volume is 21.47M. LABD market cap is $143.11M with 19.11M shares outstanding.